Clinical Trials of the LH-RH Analogue Leuprolide in Human Breast Cancer
- 1 January 1988
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerBritish Journal of Cancer, 1986
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- Gonadotropin-Releasing Hormone Binding Sites in Human Breast CarcinomaScience, 1985
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerBreast Cancer Research and Treatment, 1984
- Pituitary and Gonadal Desensitization after Continuous Luteinizing Hormone-Releasing Hormone Infusion in Normal Females*Journal of Clinical Endocrinology & Metabolism, 1980
- (DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised ratsNature, 1979
- Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female ratsBritish Journal of Cancer, 1979
- Aspects of Hypothalamic Regulation of the Pituitary GlandScience, 1978